Bath & Body Works (NYSE:BBWI) Upgraded at Barclays

Bath & Body Works (NYSE:BBWI) was upgraded by equities research analysts at Barclays from an “underweight” rating to an “equal weight” rating in a note issued to investors on Monday, MarketBeat Ratings reports. The brokerage presently has a $43.00 price objective on the stock, up from their prior price objective of $34.00. Barclays‘s price objective would indicate a potential upside of 5.99% from the company’s previous close.

A number of other equities analysts also recently issued reports on BBWI. Deutsche Bank Aktiengesellschaft upped their price target on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Piper Sandler boosted their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Morgan Stanley lowered their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. Argus reiterated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. upgraded shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $41.00 to $47.00 in a research report on Tuesday, February 18th. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $44.44.

Bath & Body Works Trading Up 1.8 %

Shares of Bath & Body Works stock opened at $40.57 on Monday. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The stock’s fifty day moving average price is $37.77 and its 200-day moving average price is $34.02. The firm has a market cap of $8.79 billion, a P/E ratio of 9.90, a P/E/G ratio of 0.92 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the previous year, the company posted $0.48 EPS. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current year.

Institutional Trading of Bath & Body Works

Institutional investors and hedge funds have recently bought and sold shares of the stock. Shufro Rose & Co. LLC acquired a new stake in Bath & Body Works during the 4th quarter valued at $343,000. American Trust purchased a new stake in shares of Bath & Body Works in the fourth quarter worth approximately $205,000. Public Employees Retirement System of Ohio acquired a new position in Bath & Body Works in the 4th quarter valued at approximately $2,920,000. Alpine Global Management LLC purchased a new stake in Bath & Body Works in the 4th quarter worth approximately $576,000. Finally, Northwest Bank & Trust Co boosted its position in Bath & Body Works by 2.9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company’s stock valued at $533,000 after purchasing an additional 419 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.